S
Shanghai Ruishi Health Technology
Manufactures massage products
About Shanghai Ruishi Health Technology
Shanghai Ruishi Health Technology Co., Ltd., operating as Ruishi Technology, is a health-tech firm established on May 19, 2017. The company focuses on the prevention and control of myopia in children and adolescents. Since its inception, Ruishi Technology has secured significant funding to support its growth and research initiatives. In December 2022, the company raised 50 million RMB in a Series A round from Bluerun Ventures and Yaojin Capital. This was followed by a substantial Series A+ round in August 2023, raising hundreds of millions of RMB from investors including Sinovation Ventures, Betaine, Yaojin Capital, and Bluerun Ventures. Most recently, in June 2025, it secured tens of millions of RMB in a Series A++ round led by Jinke Junchuang.
The company's core product is the Ruishi Distant Vision Screen, developed under the guidance of chief scientist Professor Wang Ningli, a co-inventor of the underlying technology. This device is engineered to address the root causes of myopia in young users. It employs a combination of three key technologies: simulated high-definition distant imaging, digital spectral structure, and digital defocus with blur stimulation. By integrating patented AR free-form surface technology, the screen projects a magnified, high-definition image that simulates viewing objects at a distance. This setup allows children to engage with digital learning and entertainment content without the eye strain associated with prolonged near-distance focus, thereby helping to prevent transient myopia and reduce visual fatigue. The product has been recognized with an award for scientific and technological progress in ophthalmology.
Ruishi Technology serves the expansive market for children's vision health, a significant concern given the rising prevalence of myopia. The business model appears to be centered on the sale of its specialized hardware, the Distant Vision Screen, to families and potentially educational institutions. The company's legal representative is Pan Dejiao, and a major shareholder is Yao Jun. Formerly known as Shanghai Nuanwen Information Technology Co., Ltd., the company leverages a potent mix of IoT, artificial intelligence, and big data to deliver its vision health management services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 19.7/100
- Industry
- Wellness Beauty
- Sector
- Hard Tech
- Business model
- Manufacturing
- Client focus
- B2B, B2C
- Investment activity
- 1 company, latest Mar 2022
- Capital deployed
- $0
- Preferred round
- SEED
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2025 | $2.8M | $69M | Sinovation Ventures · Huaxi Securities · Chuangxin Gongchang | ↗ |
| SERIES A✓Equity / VC | Jun 2025 | $2.8M | $69M | JC Capital | ↗ |
Growth signals
Latest recorded traffic for Shanghai Ruishi Health Technology is 300 monthly website visits, down 11.8% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Ruishi Health Technology in the Huangpu ecosystem
The Shanghai Ruishi Health Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
- SCSinopharm CICC
Lanchi Ventures
Chuangxin Gongchang- YCYaojin Capital
Yunnan Botanee Bio-Tech Group
JC Capital
Sinovation Ventures
Huaxi Securities
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Ruishi Health Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Ruishi Health Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







